Michael Fitzmaurice TD welcomes approval for cystic fibrosis drug Orkambi
Michael Fitzmaurice TD has welcomed the news this evening that the HSE has reached agreement, in principle, with the drug company Vertex for the drugs Orkambi and Kalydeco to be provided to people with cystic fibrosis from the beginning of next month. Orkambi will be provided for patients aged 12 years and older and Kalydeco
Michael Fitzmaurice TD welcomes approval for cystic fibrosis drug Orkambi Read More »










